Table 3.

Some of the main products employed for cancer therapy by using TDD systems

Carrier	Drug
Dextran nanoparticle/HA MNs	aPD1
HA nanoparticle/HA MNs	aPD1/1-Methyl-DL-tryptophan
OSM-(PEG-PAEU) and poly(I:C) layer-by-layer coated MN	Ovalbumin plasmid/poly(I:C)
PEI modified single-wall carbon nanotubes	siRNA targeting
Polyelectrolyte multilayers coated MNs	p53 DNA
SPACE-EGF fusion peptide	siRNA silencing c-Myc
Tat and PEI modified gold nanoparticles	DNA plasmid encoding microRNA-221 inhibitor gene